Zimmer Biomet Holdings (ZBH) Operating Income Growth (1y) (2010 - 2026)
Zimmer Biomet Holdings (ZBH) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 16.18% |
| 10 | Zimmer Biomet Holdings | 19.24 Bn | 18.83 Bn | 1.54 Bn | 8.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.70% |
| Mar 31, 2026 | 27.68% |
| Dec 31, 2025 | -60.28% |
| Sep 30, 2025 | 25.69% |
| Jun 30, 2025 | -14.60% |
| Mar 31, 2025 | 9.93% |
| Dec 31, 2024 | 9.82% |
| Sep 30, 2024 | 4.84% |
| Jun 30, 2024 | 6.58% |
| Mar 31, 2024 | -18.76% |
| Dec 31, 2023 | 1,351.59% |
| Sep 30, 2023 | 8.68% |
| Jun 30, 2023 | 17.34% |
| Mar 31, 2023 | 64.97% |
| Dec 31, 2022 | -121.15% |
| Sep 30, 2022 | 0.95% |
| Jun 30, 2022 | 24.96% |
| Mar 31, 2022 | 2,581.08% |
| Dec 31, 2021 | -67.49% |
| Sep 30, 2021 | -18.78% |